DOSE CALCULATION USING 4 HOUR I-131 UPTAKE FOR RETREATMENT RADIOIODINE THERAPY OF PATIENTS WITH GRAVES’ DISEASE

Authors

  • Kanaungnit KINGPETCH Department of Radiology, Faculty of Medicine, Chulalongkorn University
  • Makrumkrong POSHYACHINDA Department of Radiology, Faculty of Medicine, Chulalongkorn University

Keywords:

radionuclide therapy, 131 I, hyperthyroidism, Graves’disease, Thyroid uptake

Abstract

Objective: The purpose of this study is to evaluate the feasibility of using the 4 hour 131I uptake value in the calculation of treatment dose of radioiodine for the patients previously treated by 131I for hyperthyroidism but still having persistent symptoms. This would permit uptake measurement and therapy within the same day,thus reducing the cost and inconvenience to the patient.

Subject: One hundred and sixty Graves’disease patients who were previously treated with 131I but remain hyperthyroid are included in this study.

Method: The patients were randomly devided into 2 groups. First group was used to develop a regression relationship between 4 hr. and 24 hr 131I uptake. The second group was used to calculate the predicted therapeutic dose of 131l, which was calculated from 4 hr. 131I uptake.

Result: Correlation between 4 hr. and 24 hr. 131 I uptake is high (r= 0.71). These data allow us to develop a linear regression equation ;24 hr. 131 I uptake = 36.764 + 0.518 (4 hr. 131 I uptake ). The predicted therapeutic doses calculation using 4 hr. 131] uptake, correlate well with the calculated doses, base on the actual 24 hr. 131I uptake (r = 0.92).

Conclusion: There is a high correlation in the predicted dose derived by calculation using 4 hr 131I uptake and the actual doses calculated by using 24 hr. = uptake. Therefore, the 4 hr. 131I uptake value can be used to calculate the treatment doses of radioiodine for the previously treated patients who still have persistent hyperthyroidism

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Becker DV, Sawin CT. Radioiodine and thyroid disease: The beginning.Semin Nucl Med 1996 ;26:155-164.

Wartofsky L. Treatment options for hyperthyroidism. Hosp Prac 1996; 15;31(9) : 69-73.

Clarke SM. Radioiodine therapy of the thyroid. In: Murray IPC, Ell PJ, Strauss HW. eds. Nuclear Medicine in Clinical Diagnosis and Treatment. New York: Churchill Livingstore 1994 :1833-1845.

Hayes AA, Akre CM, Garman CA. Iodine- 131 treatment of Graves’disease using modified early Iodine-131 uptake measurement in therapy dose calculation. J Nucl Med 1990 ;31:519-522.

Hennessey JV, Berg LA, Ibrahim MA, et al. Evaluation of early (5 to 6 hours) iodine 123 uptake for diagnosis and treatment planning in Graves’disease. Arch Intern Med 1995;155:621-624.

Usha SV, Francis BA, Harvey AZ. Therapy dose calculation in Graves’ disease using early I-123 uptake measurements. Clin Nucl Med 1996 ;21(2) :102- 105.

Burch HB, Wartofsley L. Hyperthyroidism. In: Bardin CW (ed). Current therapy in exdocrinology and metabolism, 5th ed. Mosby, ST Louise 1994:64-70.

Shapiro B. Optimization of radioiodine therapy of thyrotoxicosis; what have we learned after 50 years ?.J Nucl Med 1993; 34: 1638-1641.

Kingpetch K. (unpublished data). Therapy dose calculation in unirradiated Graves’ disease using 4 hour I-131 uptake,1999.

Downloads

Published

2023-04-16

How to Cite

1.
KINGPETCH K, POSHYACHINDA M. DOSE CALCULATION USING 4 HOUR I-131 UPTAKE FOR RETREATMENT RADIOIODINE THERAPY OF PATIENTS WITH GRAVES’ DISEASE. ASEAN J Radiol [Internet]. 2023 Apr. 16 [cited 2025 Jan. 31];9(1):63-8. Available from: https://asean-journal-radiology.org/index.php/ajr/article/view/630

Issue

Section

Original Article

Similar Articles

<< < 1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.